Loading clinical trials...
Loading clinical trials...
Treatment of Superficial Basal Cell Carcinoma by Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Topical Photodynamic Therapy With Methylaminolevulinate
Conditions
Interventions
Methylaminolevulinate PDT in 2 sessions
Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT
Locations
3
Netherlands
Maastricht University Medical Center
Maastricht, Limburg, Netherlands
VieCuri Medical Centre
Venlo, Limburg, Netherlands
Erasmus Medical Centre
Rotterdam, South Holland, Netherlands
Start Date
August 1, 2013
Primary Completion Date
April 1, 2015
Completion Date
April 1, 2015
Last Updated
January 31, 2014
Lead Sponsor
Maastricht University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions